Millennium Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $164M | Buy |
1,247,447
+804,581
| +182% | +$107M | 0.07% | 263 |
|
|
2025
Q4 | $62.8M | Sell |
442,866
-534,344
| -55% | -$77.4M | 0.03% | 658 |
|
|
2025
Q3 | $137M | Sell |
977,210
-217,009
| -18% | -$29.4M | 0.06% | 304 |
|
|
2025
Q2 | $150M | Buy |
1,194,219
+617,629
| +107% | +$70.8M | 0.07% | 244 |
|
|
2025
Q1 | $63.8M | Buy |
576,590
+157,878
| +38% | +$20M | 0.03% | 593 |
|
|
2024
Q4 | $57.2M | Buy |
418,712
+105,945
| +34% | +$13.1M | 0.03% | 706 |
|
|
2024
Q3 | $36M | Buy |
312,767
+125,284
| +67% | +$17.2M | 0.02% | 1056 |
|
|
2024
Q2 | $25.8M | Sell |
187,483
-267,737
| -59% | -$36.7M | 0.01% | 1285 |
|
|
2024
Q1 | $62.8M | Sell |
455,220
-233,736
| -34% | -$31.9M | 0.03% | 692 |
|
|
2023
Q4 | $90.8M | Sell |
688,956
-579,310
| -46% | -$66.7M | 0.04% | 461 |
|
|
2023
Q3 | $143M | Buy |
1,268,266
+418,008
| +49% | +$44M | 0.07% | 222 |
|
|
2023
Q2 | $80.2M | Buy |
850,258
+281,983
| +50% | +$27.6M | 0.04% | 463 |
|
|
2023
Q1 | $57.5M | Sell |
568,275
-272,065
| -32% | -$28.3M | 0.03% | 608 |
|
|
2022
Q4 | $100M | Buy |
840,340
+267,284
| +47% | +$31.3M | 0.06% | 373 |
|
|
2022
Q3 | $60.9M | Buy |
573,056
+210,383
| +58% | +$21.3M | 0.04% | 568 |
|
|
2022
Q2 | $35.4M | Sell |
362,673
-137,454
| -27% | -$12.7M | 0.02% | 850 |
|
|
2022
Q1 | $46.9M | Sell |
500,127
-60,870
| -11% | -$5.16M | 0.02% | 734 |
|
|
2021
Q4 | $47.8M | Buy |
560,997
+69,753
| +14% | +$6.42M | 0.02% | 751 |
|
|
2021
Q3 | $47.1M | Buy |
491,244
+369,733
| +304% | +$34.9M | 0.03% | 662 |
|
|
2021
Q2 | $11.8M | Buy |
+121,511
| New | +$11.6M | 0.01% | 1708 |
|
|
2021
Q1 | – | Sell |
-225,156
| Closed | -$23.6M | – | 6316 |
|
|
2020
Q4 | $21.6M | Buy |
225,156
+182,520
| +428% | +$17.6M | 0.02% | 1008 |
|
|
2020
Q3 | $4.1K | Sell |
42,636
-16,514
| -28% | -$1.91M | 0.01% | 2019 |
|
|
2020
Q2 | $7.22M | Sell |
59,150
-57,650
| -49% | -$6.37M | 0.01% | 1460 |
|
|
2020
Q1 | $10.1M | Sell |
116,800
-269,258
| -70% | -$26.4M | 0.02% | 847 |
|
|
2019
Q4 | $41.5M | Buy |
386,058
+109,006
| +39% | +$11.4M | 0.05% | 455 |
|
|
2019
Q3 | $25M | Buy |
277,052
+73,342
| +36% | +$6.85M | 0.04% | 638 |
|
|
2019
Q2 | $17.2M | Sell |
203,710
-356,238
| -64% | -$29.3M | 0.03% | 877 |
|
|
2019
Q1 | $49.3M | Buy |
559,948
+539,208
| +2,600% | +$45.1M | 0.07% | 349 |
|
|
2018
Q4 | $1.48M | Sell |
20,740
-337,795
| -94% | -$32.4M | ﹤0.01% | 2385 |
|
|
2018
Q3 | $44.1M | Buy |
358,535
+331,346
| +1,219% | +$37.6M | 0.05% | 463 |
|
|
2018
Q2 | $2.67M | Sell |
27,189
-100,726
| -79% | -$9.02M | ﹤0.01% | 2207 |
|
|
2018
Q1 | $10.6M | Sell |
127,915
-406,651
| -76% | -$34.3M | 0.01% | 1287 |
|
|
2017
Q4 | $41.5M | Buy |
534,566
+417,661
| +357% | +$28.5M | 0.06% | 497 |
|
|
2017
Q3 | $7.16M | Buy |
+116,905
| New | +$6.17M | 0.01% | 1463 |
|
|
2017
Q1 | – | Sell |
-1,335,798
| Closed | -$51.7M | – | 3725 |
|
|
2016
Q4 | $51.7M | Buy |
1,335,798
+1,227,830
| +1,137% | +$55.6M | 0.11% | 251 |
|
|
2016
Q3 | $5.47M | Sell |
107,968
-506,608
| -82% | -$25.2M | 0.01% | 1284 |
|
|
2016
Q2 | $27.9M | Sell |
614,576
-474,339
| -44% | -$21.8M | 0.06% | 386 |
|
|
2016
Q1 | $43.1M | Buy |
1,088,915
+31,292
| +3% | +$1.24M | 0.11% | 218 |
|
|
2015
Q4 | $59.8M | Sell |
1,057,623
-267,751
| -20% | -$13.6M | 0.13% | 182 |
|
|
2015
Q3 | $52.7M | Buy |
1,325,374
+168,487
| +15% | +$8.14M | 0.1% | 228 |
|
|
2015
Q2 | $55.3M | Sell |
1,156,887
-315,986
| -21% | -$13.4M | 0.1% | 237 |
|
|
2015
Q1 | $58.5M | Buy |
1,472,873
+251,207
| +21% | +$8.99M | 0.11% | 211 |
|
|
2014
Q4 | $27.3M | Buy |
1,221,666
+879,740
| +257% | +$16.7M | 0.06% | 459 |
|
|
2014
Q3 | $5.36M | Sell |
341,926
-67,015
| -16% | -$1M | 0.01% | 1254 |
|
|
2014
Q2 | $6.07M | Buy |
+408,941
| New | +$5.77M | 0.02% | 1088 |
|
|
2014
Q1 | – | Sell |
-830,874
| Closed | -$7.76M | – | 3744 |
|
|
2013
Q4 | $7.76M | Buy |
830,874
+765,874
| +1,178% | +$7.47M | 0.02% | 866 |
|
|
2013
Q3 | $736K | Sell |
65,000
-15,819
| -20% | -$217K | ﹤0.01% | 2310 |
|
|
2013
Q2 | $1.08M | Buy |
+80,819
| New | +$993K | ﹤0.01% | 1922 |
|
Other funds holding NBIX
VPM
VCM
Millennium Management's NBIX Position: Q1 2026 in Review
Millennium Management increased its Neurocrine Biosciences (NBIX) stake by 182% in Q1 2026, buying an estimated $107M and bringing the position to 1,247,447 shares worth $164M. The position accounts for 0.07% of the portfolio, ranked #263.
Millennium Management first reported a position in NBIX in Q2 2013 and has held it in 48 quarters since. 694 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.
- Millennium Management held 1,247,447 shares of Neurocrine Biosciences worth $164M as of Q1 2026.
- Millennium Management bought 804,581 Neurocrine Biosciences shares in Q1 2026, an estimated $107M.
- Neurocrine Biosciences made up 0.07% of Millennium Management's portfolio in Q1 2026, its #263 holding.
- Millennium Management first reported a position in Neurocrine Biosciences in Q2 2013 and has held it in 48 quarters since.
- 694 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.